Drug resistance mechanisms in Mycobacterium tuberculosis

279Citations
Citations of this article
1.4kReaders
Mendeley users who have this article in their library.

Abstract

Tuberculosis (TB) is a serious public health problem worldwide. Its situation is worsened by the presence of multidrug resistant (MDR) strains of Mycobacterium tuberculosis, the causative agent of the disease. In recent years, even more serious forms of drug resistance have been reported. A better knowledge of the mechanisms of drug resistance of M. tuberculosis and the relevant molecular mechanisms involved will improve the available techniques for rapid drug resistance detection and will help to explore new targets for drug activity and development. This review article discusses the mechanisms of action of anti-tuberculosis drugs and the molecular basis of drug resistance in M. tuberculosis. © 2014 by the authors; licensee MDPI, Basel, Switzerland.

Cite

CITATION STYLE

APA

Palomino, J. C., & Martin, A. (2014, July 2). Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics. MDPI AG. https://doi.org/10.3390/antibiotics3030317

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free